RCE on 7 News, page-40

If the price gets down to around 16c I might hop on board for the ride as well.
A major concern for this company in my eyes is the ability to commercialise and generate a profit out of their product even if they do get approvals to start testing and all goes well.
In my eyes it seems like the board is full of smart scientists as well, however, the key for a board is to not only generate a great product but actually turn that into a profit for shareholders. Regardless, I do hope this company goes well, I have been closely following it since listing, it just feels like a massive risk hoping into this one, a risk I'm not sure I feel like taking just yet.